NRG HN004

Primary Category:

Radiation Oncology, Treatment Protocols

Disease Category:

Head and Neck

Status:

Closed

Randomized Phase II/III Trial of Radiotherapy with Concurrent MEDI4736 (Durvalumab) Vs. Radiotherapy with Concurrent Cetuximab in Patients with Stage III-IVB Head and Neck Cancer with a Contraindication to Cisplatin

NCT#03258554

Site Delegation of Tasks Log required prior to registration of any patients.

HN004 is permanently closed to accrual effective September 1, 2022.